Search Login Register

Dalteparin (Dalteparin Sodium) Summary

Description: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Also Known As: Dalteparin Sodium; FR-860; Fragmin; Fragmine; Kabi-2165; Pfizer Brand of Dalteparin Sodium; FR 860; FR860; Kabi 2165; Kabi2165; Sodium, Dalteparin; Tedelparin

Networked: 536 relevant articles (71 outcomes, 191 trials/studies) for this Drug

Key Diseases for which Dalteparin is Relevant

  1. Hemorrhage : 16 outcomes 11 studies in 104 results
  2. Venous Thrombosis (Deep-Vein Thrombosis) : 11 outcomes 29 studies in 90 results
  3. Myocardial Infarction : 8 outcomes 27 studies in 52 results
  4. Thrombosis (Thrombus) : 8 outcomes 16 studies in 63 results
  5. Venous Thromboembolism : 6 outcomes 22 studies in 71 results
Show All >>

Drugs Related to Dalteparin

  1. Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
  2. Heparin (Liquaemin)
  3. Enoxaparin (Lovenox)
  4. Dalteparin (Dalteparin Sodium)
  5. Nadroparin (Nadroparin Calcium)
  6. Aspirin (Acetylsalicylic Acid)
  7. Warfarin (Coumadin)
  8. certoparin (certoparin sodium)
  9. glucuronyl glucosamine glycan sulfate (Vessel)
  10. tirofiban (Aggrastat)
Show All >>

Therapies Related to Dalteparin

  1. Subcutaneous Injections
  2. Catheters
  3. Hip Replacement Arthroplasty (Total Hip Replacement)
  4. Thrombolytic Therapy
  5. Renal Dialysis (Hemodialysis)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.